Skip to main content
Midas Edge

CHAMPIONS ONCOLOGY, INC.

For the period ended Aug 27, 2026. Filed Aug 28, 2026.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Aug 27, 2026 · Filed Aug 28, 2026

CSBR$4.79+0.6%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

20.Shareholder Approval

  1. Shareholder Approval

The Plan will be subject to approval by the shareholders of the Company within twelve (12) months after the date the Plan is adopted. Such shareholder approval will be obtained in the manner and to the degree required under Applicable Law. All Awards hereunder are contingent on approval of the Plan by the Company’s shareholders. Notwithstanding any other provision of this Plan, if the Plan is not approved by the Company’s shareholders within twelve (12) months after the date the Plan is adopted, the Plan and any Awards hereunder shall be automatically terminated.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.